327 related articles for article (PubMed ID: 27194724)
1. Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
Chen E; Salinas ND; Huang Y; Ntumngia F; Plasencia MD; Gross ML; Adams JH; Tolia NH
Proc Natl Acad Sci U S A; 2016 May; 113(22):6277-82. PubMed ID: 27194724
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.
Urusova D; Carias L; Huang Y; Nicolete VC; Popovici J; Roesch C; Salinas ND; Dechavanne S; Witkowski B; Ferreira MU; Adams JH; Gross ML; King CL; Tolia NH
Nat Microbiol; 2019 Sep; 4(9):1486-1496. PubMed ID: 31133752
[TBL] [Abstract][Full Text] [Related]
3. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
mSphere; 2019 May; 4(3):. PubMed ID: 31092602
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design.
Chen E; Salinas ND; Ntumngia FB; Adams JH; Tolia NH
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003644. PubMed ID: 25793371
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ
Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755
[TBL] [Abstract][Full Text] [Related]
6. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.
Ntumngia FB; Adams JH
Clin Vaccine Immunol; 2012 Jan; 19(1):30-6. PubMed ID: 22116684
[TBL] [Abstract][Full Text] [Related]
7. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
[TBL] [Abstract][Full Text] [Related]
8. The association of Duffy binding protein region II polymorphisms and its antigenicity in Plasmodium vivax isolates from Thailand.
Chootong P; McHenry AM; Ntumngia FB; Sattabongkot J; Adams JH
Parasitol Int; 2014 Dec; 63(6):858-64. PubMed ID: 25108177
[TBL] [Abstract][Full Text] [Related]
9. Human antibodies against DBP.
Richards JS; Ramsland PA
Nat Microbiol; 2019 Sep; 4(9):1428-1429. PubMed ID: 31439930
[No Abstract] [Full Text] [Related]
10. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
[TBL] [Abstract][Full Text] [Related]
11. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.
Ntumngia FB; King CL; Adams JH
Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period.
Medeiros CMP; Moreira EUM; Pires CV; Torres LM; Guimarães LFF; Alves JRS; Lima BAS; Fontes CJF; Costa HL; Brito CFA; Sousa TN; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
PLoS One; 2020; 15(5):e0232786. PubMed ID: 32379804
[TBL] [Abstract][Full Text] [Related]
13. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies.
Chootong P; Ntumngia FB; VanBuskirk KM; Xainli J; Cole-Tobian JL; Campbell CO; Fraser TS; King CL; Adams JH
Infect Immun; 2010 Mar; 78(3):1089-95. PubMed ID: 20008533
[TBL] [Abstract][Full Text] [Related]
14. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand.
Chootong P; Panichakul T; Permmongkol C; Barnes SJ; Udomsangpetch R; Adams JH
PLoS One; 2012; 7(4):e35769. PubMed ID: 22558221
[TBL] [Abstract][Full Text] [Related]
15. Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies.
Ntumngia FB; Schloegel J; Barnes SJ; McHenry AM; Singh S; King CL; Adams JH
Infect Immun; 2012 Mar; 80(3):1203-8. PubMed ID: 22215740
[TBL] [Abstract][Full Text] [Related]
16. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
[TBL] [Abstract][Full Text] [Related]
17. An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies.
Ntumngia FB; Pires CV; Barnes SJ; George MT; Thomson-Luque R; Kano FS; Alves JRS; Urusova D; Pereira DB; Tolia NH; King CL; Carvalho LH; Adams JH
Sci Rep; 2017 Oct; 7(1):13779. PubMed ID: 29062081
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
[TBL] [Abstract][Full Text] [Related]
19. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
